Congo's minister of health says the first death from a new outbreak of Ebola in the country's northwest has been confirmed along with 11 other cases of people sickened by the virus.
May 10, 2018
0
2
For a long time, a dengue vaccine was the holy grail in dengue research. Now that a dengue vaccine is finally on the market (Sanofi's Dengvaxia), other issues have arisen, such as what happens in the babies of vaccinated ...
Dec 22, 2017
0
9
Individuals infected with Zika virus after having dengue fever do not appear to become more severely ill than people with Zika who have never had dengue. This is the conclusion of a study published on June 20 in the journal ...
Jul 17, 2017
0
2
A public health alert for 150 dengue fever cases has been issued in Mombasa, Kenya. The Conversation Africa's Health and Medicine Editor Joy Wanja Muraya spoke to Dr Andrew Githeko on the effective management of this disease ...
May 10, 2017
0
0
With Zika virus raising concerns around the United States about the spread of mosquito-borne diseases, the transmission of these viruses has become paramount in terms of how, when and where they are spread. Researchers at ...
Oct 7, 2016
0
3
A research team spanning four continents has detailed the anti-viral capabilities of OSU-03012, also known as AR-12, a drug currently used in clinical trials to treat certain cancer tumors. The present study confirms that ...
Jul 5, 2016
0
96
The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as two weeks. That may not leave enough time for the immune system to mount an effective response.
Oct 30, 2015
0
110
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists.
Sep 9, 2015
0
13
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The findings were recently published ...
Jul 13, 2015
0
124
Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.
Apr 17, 2015
0
50
